The study was well organised, and did legitimately demonstrate an increased risk of eye damage in people taking Ozempic
Abe H, Uchida T, Hara A, Mizukami H, Komiya K, Koike M, et al
EMPA-KIDNEY included 1,803 (55%) patients treated with JARDIANCE 65 years of age and older, and 758 (23%) patients 75 years of age and older
Future research should prioritize collaborative, methodologically robust investigations to bridge Eastern and Western medical perspectives, while aiming to improve prevention, treatment, and long-term outcomes for individuals at risk of or affected by HACE worldwide
This gap leaves millions seeking weight loss treatment without pharmaceutical coverage, creating financial barriers to accessing proven GLP-1 therapy
Naltrexone and low dose naltrexone have both also been shown to reduce inflammation in the body